Company Long-Term Loans and Borrowings: Jupiter Neurosciences Inc (JUNS)

Public company logo of Jupiter Neurosciences (JUNS)

Jupiter Neurosciences Inc (JUNS) is implementing automated molecule selection stations and research data processing software. The asset value on the GURU.Markets platform, which stands at 0.00 as shown on the chart, correlates with successes in neuron degeneration therapy, formula protection, and the search for distributors. However, business sustainability is constrained by the complexities of Alzheimer's drug trials, capital shortages, and high uncertainty within the CNS field.

jupiterneurosciences.com (JUNS) Company Long-Term Debt: for the period 12/04/2024 - 10/29/2026

Summary analytical data breakdowns for Jupiter Neurosciences (JUNS)

- market price and analyst price targets:
Stock Price jupiterneurosciences.com|JUNS - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Jupiter Neurosciences|JUNS - Total Company Value
- book capitalization information:
Net Asset Value per Share Jupiter Neurosciences|JUNS - Company Book Value|Market Cap to Book Value Multiple jupiterneurosciences.com|JUNS - Cumulative Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Jupiter Neurosciences Inc|JUNS - Long-Term Debt to Equity|Current Liabilities to Equity Jupiter Neurosciences, Inc.|JUNS - Company Aggregate Debts|Debts to Net Assets Jupiter Neurosciences|JUNS - Company Long-Term Liabilities|Amount of Current Liabilities Jupiter Neurosciences
Summary company analytics:JUNS jupiterneurosciences.com
Original product of Jupiter Neurosciences, Inc.

The integration of robotic systems and AI into the drug development processes of Jupiter Neurosciences Inc. (JUNS) requires significant capital expenditures, making the monitoring of credit leverage critically important. An analysis of total liabilities with maturities exceeding one year allows for an assessment of systemic default risk and the issuer's solvency, while the trend of the business's long-term debt serves as an indicator of the balance between aggressive growth and financial stability.

Competitor analysis for Jupiter Neurosciences Inc

Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Debt Xenon Pharmaceuticals|VKTX (vikingtherapeutics.com) - Amount of Long-Term Liabilities|Company Long-Term Liabilities SUPN (Supernus)|Company Long-Term Debts Catalyst Pharma (CPRX)|Company Long-Term Debt Denali Therapeutics Inc DNLI|HRMY (Harmony Corp) - Long-Term Liabilities|Biohaven Ltd. - Company Long-Term Debts|Long-Term Debt Volume amylyx.com AMLX|TRVI (Trevi Therapeutics, Inc.) - Company Long-Term Liabilities|PRAX: Amount of Long-Term Liabilities|AVXL (Anavex Corp) - Company Long-Term Debts|Long-Term Debt CeriBell EEG CBLL|Company Long-Term Debt Prothena (PRTA)|ALEC (alector.com) - Company Long-Term Loans and Borrowings|Annexon - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings OMER|NGNE - Company Long-Term Debt|ACIU (AC Immune Inc) - Company Long-Term Indebtedness|VYGR: Company Long-Term Debts|Long-Term Debt neumoratx.com (NMRA)|Company Long-Term Liabilities SCLX|Company Long-Term Debts Tevogen Bio Holdings Inc.|Company Long-Term Debt Alpha Cognition (ACOG)|CGTX (cogrx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Inhibikase Therapeutics IKT|cassavasciences.com (SAVA) - Long-Term Debt|ASRT - Company Long-Term Debt|Long-Term Debt Volume Coya Therapeutics, Inc. COYA|VTGN: Company Long-Term Debts|Company Long-Term Liabilities Ovid Therapeutics|ABOS (Acumen Pharmaceuticals) - Company Long-Term Debts|cervomed.com (CRVO) - Long-Term Debt Volume|Company Long-Term Debts ATHE|CLNN - Long-Term Debt|Company Long-Term Debt PepGen PEPG|RLMD: Company Long-Term Indebtedness|Annovis Bio, Inc. - Company Long-Term Debts|Grace Therapeutics, Inc. (GRCE) - Company Long-Term Liabilities|AIFF: Company Long-Term Debts|Long-Term Debt Klotho Neurosciences (KLTO)|Company Long-Term Debt NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals, Inc. (RVPH) - Long-Term Debt Volume|Company Long-Term Liabilities MTVA (MetaVia Inc)|NRXS (neuraxis.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts HSDT (Helius Medical Technologies)|Long-Term Debt Volume Passage Bio Inc. (PASG)|NEUP - Company Long-Term Debt|NERV (Minerva) - Company Long-Term Indebtedness|ATHA: Company Long-Term Debts|Company Long-Term Liabilities addextherapeutics.com|Company Long-Term Debt Alzamend Neuro Inc.|CYCN (Cyclerion) - Amount of Long-Term Liabilities|Company Long-Term Liabilities PTIX (Protagenic Therapeutics)|Company Long-Term Debts pasitheaclinics.com (KTTA)|Company Long-Term Debt Cortigent CRGT|ATXI: Company Long-Term Indebtedness|BCLI - Company Long-Term Debt|Long-Term Debt Volume Cara Therapeutics Inc. CARA|Chromocell Therapeutics Corporation (CHRO) - Company Long-Term Debt|Company Long-Term Indebtedness ELYM|ITCI (Intra-Cellular Therapies Inc.) - Company Long-Term Debts|Long-Term Debt longboardpharma.com LBPH|Company Long-Term Liabilities MRNS (Marinus Pharmaceuticals, Inc.)|Company Long-Term Debts NKGen Biotech Inc (NKGN)|Company Long-Term Debt NeuroBo NRBO|Company Long-Term Loans and Borrowings SAGE|SNPX - Company Long-Term Debt|Long-Term Debt trevena.com|vigilneuro.com (VIGL) - Company Long-Term Debt|WENA: Amount of Long-Term Liabilities|Company Long-Term Liabilities CERE